Lorrine Bournot
YOU?
Author Swipe
Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans Open
The new generation of incretin-based therapies are potent anti-obesity medications (AOMs) that offer the first non-surgical treatment for 936 million patients globally suffering from being overweight or obese[1]. However, clinical data sug…
Vitamin D modulates the content of inflammatory <span>microRNAs</span> in extracellular vesicles from human adipocyte cells in inflammatory context Open
Inflammation of adipose tissue is a contributing factor to many chronic diseases associated with obesity. We previously showed that micronutrients such as vitamin D (VD) limited this metabolic inflammation by decreasing inflammatory marker…
Vitamin D metabolism is altered during aging alone or combined with obesity in male mice Open
Aging and obesity are associated with a decrease in plasma 25‐hydroxyvitamin D (25(OH)D) levels. In the context of a growing aging population and the rising incidence of obesity, we hypothesized that aging process, either independently or …